YDUQS, BRYDUQACNOR3

YDUQS stock: Q3 cash flow reaches BRL 364 million as Afya vote nears

Published on 11/20/2026 at 00:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
YDUQS stock faces a November 25 shareholder vote on the proposed Afya merger. Management kept its 2026 cash-generation outlook unchanged.

Cash flow and merger milestones

  • YDUQS generated record FCFE of BRL 364 million in the third quarter.
  • The company reaffirmed its 2026 FCFE guidance of BRL 520 million to BRL 620 million.
  • Shareholders are scheduled to vote on the proposed Afya combination on November 25.
YDUQS, BRYDUQACNOR3, Illustration mit AI erstellt.

YDUQS presented its third-quarter 2026 results on November 13, highlighting record cash generation while adjusted profitability remained under pressure. Investing.com reported that free cash flow to equity reached BRL 364 million in the quarter, while adjusted EBITDA fell 3% to BRL 490 million.

Record cash generation leads results

YDUQS generated BRL 565 million of FCFE in the first nine months, putting the company within its full-year guidance range of BRL 520 million to BRL 620 million. Revenue rose 2% to BRL 1.375 billion, but the adjusted EBITDA margin narrowed to 36% as the company invested in academic quality and regulatory compliance.

Operational trends were mixed across the portfolio. IDOMED added more than 3,000 students during 2026, while Ibmec increased undergraduate intake by 9%. Digital enrollment declined 44% year over year as YDUQS reduced exposure to lower-margin distance learning programs.

Afya vote sets next milestone

The proposed combination with Afya remains subject to shareholder approval and clearance from Brazil's antitrust authority CADE. YDUQS has called an extraordinary general meeting for November 25, with closing expected within 12 months subject to the required approvals. Integration planning is already organized across academic, operational, technology and people-related workstreams.

Management reaffirmed its 2026 outlook, including earnings per share of BRL 1.40 to BRL 2.00. The company expects fourth-quarter margins to benefit from lower ENAMED-related spending, improved IDOMED profitability and lower financial expenses.

Brazilian education platform

YDUQS operates a Brazilian higher-education platform spanning Estácio and Wyden, the medical-education brand IDOMED, and the premium Ibmec business and law-school brand. Its activities cover on-campus, semi-on-campus and digital formats, with Brazil as its main market. The portfolio combines large-scale higher education with more specialized medical, business and law programs.

YDUQS company facts

  • Company: YDUQS Participações S.A.
  • Ticker: YDUQ3
  • Exchange: B3
  • Sector: Higher education
  • Headquarters: Brazil

Brazil's Bovespa index provides the broader market backdrop for Brazilian education shares.

More news and analyses on YDUQS stock.

Disclaimer...
en | BRYDUQACNOR3 | YDUQS | boerse | 70538168 | bgmi